| Bioactivity assessment and toxicity of crocin: a comprehensive review SH Alavizadeh, H Hosseinzadeh Food and chemical toxicology 64, 65-80, 2014 | 414 | 2014 |
| Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids M Hatamipour, A Sahebkar, SH Alavizadeh, M Dorri, MR Jaafari Iranian journal of basic medical sciences 22 (3), 282, 2019 | 95 | 2019 |
| Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma M Rastgoo, H Hosseinzadeh, H Alavizadeh, A Abbasi, Z Ayati, MR Jaafari Planta medica 79 (06), 447-451, 2013 | 89 | 2013 |
| Redox-sensitive nanoscale drug delivery systems for cancer treatment E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ... International journal of pharmaceutics 589, 119882, 2020 | 77 | 2020 |
| Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, ... Acta tropica 128 (3), 528-535, 2013 | 63 | 2013 |
| Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models SH Alavizadeh, J Akhtari, A Badiee, S Golmohammadzadeh, MR Jaafari Expert opinion on drug delivery 13 (3), 325-336, 2016 | 56 | 2016 |
| Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors J Akhtari, SM Rezayat, M Teymouri, SH Alavizadeh, F Gheybi, A Badiee, ... International journal of pharmaceutics 505 (1-2), 89-95, 2016 | 47 | 2016 |
| Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis MR Jaafari, M Hatamipour, SH Alavizadeh, A Abbasi, Z Saberi, S Rafati, ... International journal for parasitology: drugs and drug resistance 11, 156-165, 2019 | 46 | 2019 |
| The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma SH Alavizadeh, A Badiee, S Golmohammadzadeh, MR Jaafari International journal of pharmaceutics 473 (1-2), 326-333, 2014 | 44 | 2014 |
| Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice Z Kavian, SH Alavizadeh, S Golmohamadzadeh, A Badiee, ... Acta tropica 196, 142-149, 2019 | 39 | 2019 |
| The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells E Zendehdel, E Abdollahi, AA Momtazi‐Borojeni, M Korani, ... Journal of Cellular Biochemistry 120 (4), 4739-4747, 2019 | 34 | 2019 |
| Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies E Marzban, SH Alavizadeh, M Ghiadi, M Khoshangosht, ... Colloids and surfaces B: biointerfaces 136, 885-891, 2015 | 33 | 2015 |
| Determination of toxic element levels (lead and cadmium) in commonly used cosmetic products in Iran S Balarastaghi, Z Khashaiarmanesh, P Makhdoumi, SH Alavizadeh, ... Toxin Reviews 37 (2), 117-122, 2018 | 25 | 2018 |
| Therapeutic efficacy of cisplatin thermosensitive liposomes upon mild hyperthermia in C26 tumor bearing BALB/c mice SH Alavizadeh, F Gheybi, AR Nikpoor, A Badiee, S Golmohammadzadeh, ... Molecular pharmaceutics 14 (3), 712-721, 2017 | 24 | 2017 |
| The role of liposome–protamine–DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice SH Alavizadeh, A Badiee, A Khamesipour, SA Jalali, H Firouzmand, ... Experimental parasitology 132 (3), 313-319, 2012 | 22 | 2012 |
| Redox-sensitive doxorubicin liposome: A formulation approach for targeted tumor therapy E Mirhadi, M Mashreghi, A Askarizadeh, A Mehrabian, SH Alavizadeh, ... Scientific reports 12 (1), 11310, 2022 | 20 | 2022 |
| Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B M Iman, Z Huang, SH Alavizadeh, FC Szoka Jr, MR Jaafari Antimicrobial agents and chemotherapy 61 (9), 10.1128/aac. 02525-16, 2017 | 20 | 2017 |
| Chemotherapeutic activity of Silymarin combined with doxorubicin liposomes in 4T1 breast cancer cells F Gheybi, SH Alavizadeh, SM Rezayat, E Zendedel, M Jaafari Nanomedicine Research Journal 4 (1), 29-34, 2019 | 18 | 2019 |
| Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art SM Hosseinikhah, F Gheybi, SA Moosavian, MA Shahbazi, MR Jaafari, ... Journal of Drug Targeting 31 (1), 32-50, 2023 | 16 | 2023 |
| Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo SM Haftcheshmeh, MR Jaafari, M Mashreghi, A Mehrabian, ... Journal of Drug Delivery Science and Technology 62, 102351, 2021 | 16 | 2021 |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical Nanotechnologymums.ac.ir üzerinde doğrulanmış e-posta adresine sahip
